First PREMIER Bank’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Hold |
670
| – | – | 0.01% | 236 |
|
|
2025
Q1 | $43K | Hold |
670
| – | – | 0.01% | 235 |
|
|
2024
Q4 | $45K | Hold |
670
| – | – | 0.01% | 227 |
|
|
2024
Q3 | $47K | Hold |
670
| – | – | 0.01% | 238 |
|
|
2024
Q2 | $43K | Hold |
670
| – | – | 0.01% | 219 |
|
|
2024
Q1 | $43K | Hold |
670
| – | – | 0.01% | 219 |
|
|
2023
Q4 | $44K | Hold |
670
| – | – | 0.01% | 220 |
|
|
2023
Q3 | $38K | Hold |
670
| – | – | 0.01% | 229 |
|
|
2023
Q2 | $41K | Hold |
670
| – | – | 0.01% | 236 |
|
|
2023
Q1 | $42K | Buy |
+670
| New | +$42K | 0.01% | 243 |
|